A new ELISA kit which uses a combination of Plasmodium falciparum extract and recombinant Plasmodium vivax antigens as an alternative to IFAT for detection of malaria antibodies
Authors:
- Cecile DodererCDCecile Doderer
- Aurelie HeschungAHAurelie Heschung
- Phillippe GuntzPGPhillippe Guntz
- Jean-Pierre CazenaveJCJean-Pierre Cazenave
- Yves HansmannYHYves Hansmann
- Alexandre SenegasASAlexandre Senegas
- Alexander W PfaffAPAlexander W Pfaff
- Tamer AbdelrahmanTATamer Abdelrahman
- Ermanno CandolfiECErmanno Candolfi
Open Access
- 21 February 2007
- journal article
- research article
- Published by Springer Nature in Malaria Journal
- Vol. 6 (1) , 19
Abstract
Background: The methods most commonly used to measure malarial antibody titres are the Indirect Fluorescence Antibody Test (IFAT), regarded as the gold standard, and the Enzyme-Linked ImmunoSorbent Assay (ELISA). The objective here was to assess the diagnostic performance, i.e. the sensitivity and specificity, of a new malaria antibody ELISA kit in comparison to IFAT. This new ELISA kit, the ELISA malaria antibody test (DiaMed), uses a combination of crude soluble Plasmodium falciparum extract and recombinant Plasmodium vivax antigens. Methods: Two groups were used: 95 samples from malaria patients to assess the clinical sensitivity and 2,152 samples from blood donors, who had not been exposed to malaria, to assess the clinical specificity. Results: The DiaMed ELISA test kit had a clinical sensitivity of 84.2% and a clinical specificity of 99.6% as compared with 70.5% and 99.6% respectively, using the IFAT method. The ELISA method was more sensitive than the IFAT method for P. vivax infections (75% vs. 25%). However, in 923 malaria risk donors the analytical sensitivity of the ELISA test was 40% and its specificity 98.3%, performances impaired by large numbers of equivocal results non-concordant between ELISA and IFAT. When the overall analytical performances of ELISA was compared to IFAT, the ELISA efficiency J index was 0.84 versus 0.71 for IFAT. Overall analytical sensitivity was 93.1% and the analytical specificity 96.7%. Overall agreement between the two methods reached 0.97 with a reliability k index of 0.64. Conclusion: The DiaMed ELISA test kit shows a good correlation with IFAT for analytical and clinical parameters. It may be an interesting method to replace the IFAT especially in blood banks, but further extensive investigations are needed to examine the analytical performance of the assay, especially in a blood bank setting.Keywords
This publication has 28 references indexed in Scilit:
- Malaria and blood transfusionVox Sanguinis, 2006
- Transfusion‐transmitted malaria: current donor selection guidelines are not sufficientVox Sanguinis, 2005
- The efficacy of a malarial antibody enzyme immunoassay for establishing the reinstatement status of blood donors potentially exposed to malariaVox Sanguinis, 2005
- European strategies against the parasite transfusion riskTransfusion Clinique et Biologique, 2005
- Evaluation of a malarial antibody assay for use in the screening of blood and tissue products for clinical useVox Sanguinis, 2004
- ELISA detection of vivax malaria with recombinant multiple stage-specific antigens and its application to survey of residents in endemic areasThe Korean Journal of Parasitology, 2003
- Potential value of Plasmodium falciparum‐associated antigen and antibody detection for screening of blood donors to prevent transfusion‐transmitted malariaTransfusion, 2002
- Malaria in 2002Nature, 2002
- Evaluation of a Malaria Antibody ELISA and Its Value in Reducing Potential Wastage of Red Cell Donations from Blood Donors Exposed to Malaria, with a Note on a Case of Transfusion‐Transmitted MalariaVox Sanguinis, 1997
- Prévention du paludisme post-transfusionnel par séro-dépistage des porteurs latents de plasmodium parmi les donneurs de sangRevue Française de Transfusion et Immuno-hématologie, 1976